Cyclacel Pharmaceuticals
Latest round
- Series D
Last raised
- Jan 2004
Total raised
- $87M
Investors
- 24
About Cyclacel Pharmaceuticals
Founded in 1992 and based in New Jersey, US, Cyclacel Pharmaceuticals, Inc. develops oral therapies and small molecule cycle inhibitors to target the various phases of cell cycle control for the treatment of cancer and other serious diseases.
Who invested in Cyclacel Pharmaceuticals
24 investors across 2 rounds
See all investors in Cyclacel Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cyclacel Pharmaceuticals
Who invested in Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals has 24 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cyclacel Pharmaceuticals raised?
Cyclacel Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cyclacel Pharmaceuticals last raise money?
Cyclacel Pharmaceuticals's most recent round on record is a Series D, in Jan 2004.
What does Cyclacel Pharmaceuticals do?
Founded in 1992 and based in New Jersey, US, Cyclacel Pharmaceuticals, Inc.
Where is Cyclacel Pharmaceuticals headquartered?
Cyclacel Pharmaceuticals is headquartered in Berkeley Heights, US.
Which VCs invest in companies like Cyclacel Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cyclacel Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Cyclacel Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.